A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines

Published:2016-08-21 Issue:1 Volume:36 Page:43-53
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Cunanan Kristen M.¹,Koopmeiners Joseph S.²^ORCID

Affiliation:

1. Research Fellow, Department of Epidemiology and Biostatistics; Memorial Sloan Kettering Cancer Center; New York 10017 NY U.S.A.

2. Assistant Professor, Division of Biostatistics; School of Public Health, University of Minnesota; Minneapolis 55455 MN U.S.A.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference20 articles.

1. Design and analysis of phase I clinical trials;Storer;Biometrics,1989

2. Continual reassessment method: a practical design for phase 1 clinical trials in cancer;O'Quigley;Biometrics,1990

3. The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes;Braun;Controlled Clinical Trials,2002

4. Dose-finding based on efficacy-Toxicity trade-offs;Thall;Biometrics,2004

5. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial;Nebiyou Bekele;Biometrics,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bayesian pharmacokinetics integrated phase I–II design to optimize dose-schedule regimes;Biostatistics;2024-09-13

2. Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review;Clinical and Translational Science;2024-05

3. Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges;Frontiers in Pharmacology;2023-11-23

4. Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study;Journal of Clinical Oncology;2023-01-10

5. Basket Trials: Review of Current Practice and Innovations for Future Trials;Journal of Clinical Oncology;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3